Search Results
Viewing: 6051-6060 of 11842 | All
Article
Current Studies
Learn more about the current studies in the Child Brain and Development Lab.
Article
Meet Our Team
Ahna L. Pai, PhD Principal Investigator Dr. Pai’s areas of research focus include medication adherence in children with chronic illness, development of behavioral interventions, randomized clinical trial methodology and measure development.
Article
The Child Brain and Development Lab Staff
Learn more about principal investigator H. Gerry Taylor, PhD, and his dynamic team in the Taylor Lab.
Article
Rasmussen Lab Staff
Under the direction of Sara Rasmussen, MD, PhD, the Rasmussen Lab is dedicated to investigating the role that Human Endogenous Retrovirus K (HERV-K) has in the cellular transcriptome of pediatric tumors.
Article
Jackson Lab Staff
Learn more about principal investigator Jamie L. Jackson, PhD, and her dynamic team in the Jackson Lab.
Article
Fox Lab Staff
Kristen R. Fox, PhD Principal Investigator kristen.fox@nationwidechildrens.org Kristen Fox, PhD, is a principal investigator in the Center for Biobehavioral Health and an Assistant Professor of Pediatrics at The Ohio State University College of Medicine. Dr.
Article
Germain Accelerator Program
Accelerator programs at Nationwide Children’s Hospital transform patient care, improve health equity and access to care and benefit the community.
Specialty
Center for Pediatric Trauma Research
Established in 2013, the Center for Pediatric Trauma Research at Nationwide Children’s Hospital conducts research to achieve best outcomes for pediatric trauma patients.
Article
Gerhardt Lab
Under the direction of Center for Biobehavioral Health Director and Principal Investigator Cynthia Gerhardt, PhD, the Gerhardt Lab explores how children and families are affected by life threatening illnesses such as childhood cancer to develop interventions that improve the experiences of these illnesses. Learn more about the Gerhardt Lab and explore current projects.
Article
June 2011
Dr. Paul Martin discusses how the CMAH gene deletion in the mdx mouse model of duchenne muscular dystrophy helps better mimic the more severe aspects of DMD.